Safety and efficacy of endoscopic ultrasound guided fine needle aspiration with core biopsy needle for pancreatic mass: A prospective study

Safety and efficacy of endoscopic ultrasound guided fine needle aspiration with core biopsy needle for pancreatic mass: A prospective study - ProCore Study for Pancreatic Mass

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025738

Enrollment

Registered

2017-01-19

Start date

2017-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Mass

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with a solid pancreatic mass larger than 15 mm which required EUS-FNA for pathological confirmation

Exclusion criteria

Exclusion criteria: (1) difficulty in endoscopic approach due to prior gastroduodenal surgery, (2) daily use of anti-coagulant medicine, (3) platelet count of less than 50,000mm3, (4) PT-INR of more than 1.5.

Design outcomes

Primary

Measure	Time frame
accurate histological diagnosis	—

Countries

Japan

Contacts

Public ContactRyo Kanata

The Cancer Institute Hospital of JFCR Department of Gastroenterology

ryo.kanata@jfcr.or.jp03-3520-0111

Outcome results